In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

por Hilliard, Jamese J., Fernandez, Jeffrey, Melton, John, Macielag, Mark J., Goldschmidt, Raul, Bush, Karen, Abbanat, Darren
Publicado 2009

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone

por Morrow, Brian J., He, Wenping, Amsler, Karen M., Foleno, Barbara D., Macielag, Mark J., Lynch, A. Simon, Bush, Karen
Publicado 2010

Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes

por Zhang, Xuqing, Zhu, Bin, Guo, Lili, Bakaj, Ivona, Rankin, Matthew, Ho, George, Kauffman, Jack, Lee, Seunghun P., Norquay, Lisa, Macielag, Mark J.
Publicado en ACS Med Chem Lett (2021)

In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

por Foleno, Barbara D., Abbanat, Darren, Goldschmidt, Raul M., Flamm, Robert K., Paget, Steve D., Webb, Glenda C., Wira, Ellyn, Macielag, Mark J., Bush, Karen
Publicado 2007

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

por Schalk-Hihi, Céline, Schubert, Carsten, Alexander, Richard, Bayoumy, Shariff, Clemente, Jose C, Deckman, Ingrid, DesJarlais, Renee L, Dzordzorme, Keli C, Flores, Christopher M, Grasberger, Bruce, Kranz, James K, Lewandowski, Frank, Liu, Li, Ma, Hongchang, Maguire, Diane, Macielag, Mark J, McDonnell, Mark E, Mezzasalma Haarlander, Tara, Miller, Robyn, Milligan, Cindy, Reynolds, Charles, Kuo, Lawrence C
Publicado 2011